Improving Anemia in Inflammatory Bowel Disease: Impact of the Anemia Care Pathway

ConclusionsAcross 1  year, we observed gaps in the screening and treatment of anemia in IBD. Although screening rates did not improve, the ACP appeared to reduce missed opportunities for iron therapy by about half. Most importantly, this was associated with an overall decrease in anemia prevalence. Future refinements to the ACP should be focused on enhanced screening and follow-up.
Source: Digestive Diseases and Sciences - Category: Gastroenterology Source Type: research